SEC Form 4 · accession 0001140361-15-013939
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Richman
Director
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2015 | A | 6,818 | $0.00 | A | 15,060 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.53 | Mar 30, 2015 | A | 71,410 | A | — | Mar 30, 2025 | Common Stock | 71,410 | 71,410 | D |
| Stock Option (Right to Buy)F2 | $0.53 | Mar 30, 2015 | A | 23,804 | A | — | Mar 30, 2025 | Common Stock | 23,804 | 23,804 | D |
Explanation of responses
- F150% excercisable on grant date of March 30, 2015 and the balance vests on December 31, 2015.
- F250% excercisable on grant date of March 30, 2015 and the balance vests on March 30, 2016.